作者: G. Beets , F. Penninckx , C. Schiepers , L. Filez , L. Mortelmans
关键词: Recurrent Colorectal Cancer 、 Radiology 、 Positron emission tomography 、 Medicine 、 Metastasis 、 Recurrent Colorectal Carcinoma 、 Carcinoembryonic antigen 、 Prospective cohort study 、 Nuclear medicine 、 Rectum 、 Fluorodeoxyglucose
摘要: To assess the clinical value of whole-body positron emission tomography (PET) with [18F]fluorodeoxyglucose (FDG) in recurrent colorectal cancer, 35 patients were studied: 15 had resectable liver metastases, one a lung metastasis, eight pelvic recurrence, presacral mass equivocal findings on imaging, and three increasing serum levels carcinoembryonic antigen (CEA) without or radiological signs disease. PET affected management decisions seven 16 metastatic In recurrence demonstrated by computed (CT), detected unknown pulmonary metastases. five masses CT findings, was correct unexpected distant metastases these patients. two CEA normal identified. Overall, 14 is valuable tool for staging local